|
ACTN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19210000046633E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47199999999981E-05 |
| Normal-vs-Stage2 |
3.362200E-02 |
| Normal-vs-Stage3 |
2.41399999989511E-07 |
| Normal-vs-Stage4 |
1.368030E-04 |
| Stage1-vs-Stage2 |
3.469000E-01 |
| Stage1-vs-Stage3 |
2.032500E-02 |
| Stage1-vs-Stage4 |
6.841700E-02 |
| Stage2-vs-Stage3 |
2.639600E-02 |
| Stage2-vs-Stage4 |
3.819600E-02 |
| Stage3-vs-Stage4 |
6.799400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.04049999955147E-07 |
| Normal-vs-AfricanAmerican |
1.595680E-02 |
| Normal-vs-Asian |
1.539640E-02 |
| Caucasian-vs-AfricanAmerican |
3.051000E-01 |
| Caucasian-vs-Asian |
6.247400E-01 |
| AfricanAmerican-vs-Asian |
3.800400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70070000199618E-08 |
| Normal-vs-Female |
1.120230E-03 |
| Male-vs-Female |
2.459900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.827180E-04 |
| Normal-vs-Age(41-60Yrs) |
3.04409999984934E-07 |
| Normal-vs-Age(61-80Yrs) |
5.61059999999447E-05 |
| Normal-vs-Age(81-100Yrs) |
5.468800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.399400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.442000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.266200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.113190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.882300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.375600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.326060E-02 |
| Normal-vs-Grade 2 |
3.67780000000151E-05 |
| Normal-vs-Grade 3 |
3.39569999996403E-06 |
| Normal-vs-Grade 4 |
8.1430000000049E-05 |
| Grade 1-vs-Grade 2 |
6.306200E-01 |
| Grade 1-vs-Grade 3 |
9.335800E-01 |
| Grade 1-vs-Grade 4 |
2.940000E-01 |
| Grade 2-vs-Grade 3 |
3.479800E-01 |
| Grade 2-vs-Grade 4 |
4.975800E-02 |
| Grade 3-vs-Grade 4 |
1.347190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.064400E-03 |
| Normal-vs-ccB subtype |
7.07999991966801E-10 |
| ccA subtype-vs-ccB subtype |
1.89280000006953E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67055999999999E-05 |
| Normal-vs-N1 |
1.032240E-02 |
| N0-vs-N1 |
9.643600E-01 |
|
|
